Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ebola Vaccine Possible, but Many Doubts Persist
NY Times
Saturday, August 2, 2014 - 10:37am
tags:
vaccines, ebola virus
Harvard Study Questioning Cholesterol Drugs in Low-Risk Cases Survives Oxford Challenge
BusinessWeek
Saturday, August 2, 2014 - 10:33am
tags:
hypercholesterolemia, statins
ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire
Yahoo/PR NewsWire
Saturday, August 2, 2014 - 10:06am
tags:
ANI Pharmaceuticals, Vancocin, Shire
Start-Ups Work on Biotech Drugs for Pets
NY Times
Saturday, August 2, 2014 - 10:02am
tags:
veterinary medicine
Wall Street Transcript Interview with Charles R. Kummeth, the President and CEO of Bio-Techne (TECH)
Yahoo/Wall Street Transcript
Saturday, August 2, 2014 - 10:00am
tags:
Bio-Techne
Cel-Sci's Enrollment Math Doesn't Add up
The Street
Saturday, August 2, 2014 - 9:58am
tags:
Cel-Sci
Most popular news headlines for Friday, August 1 2014
CP Wire
Saturday, August 2, 2014 - 9:34am
tags:
Sanofi, Pharmacyclics, layoffs, Jardiance, Imbruvica, Eli Lilly, diabetes, Boehringer Ingelheim, Amgen
3 Stocks Pushing The Drugs Industry Lower
TheStreet.com
Saturday, August 2, 2014 - 7:54am
tags:
Valeant Pharmaceuticals, Allergan, AbbVie
Teva gets more than half of U.S. Copaxone patients converted to long-lasting version
Fierce Pharma
Friday, August 1, 2014 - 6:16pm
tags:
Teva Pharmaceutical, MS, multiple sclerosis, Copaxone
What’s in a Name? WHO Issues Proposal for Biosimilar Names
WSJ Online
Friday, August 1, 2014 - 6:15pm
tags:
WHO, biosimilars, drug names
Valeant calls Allergan lawsuit 'frivolous'
Marketwatch
Friday, August 1, 2014 - 6:11pm
tags:
Valeant, Allergan, M&A
Repealing The Medical-Device Excise Tax: Next Steps
Forbes
Friday, August 1, 2014 - 6:08pm
tags:
devices, medical device tax
FDA approves Lilly, Boehringer diabetes drug
Yahoo/AP
Friday, August 1, 2014 - 6:07pm
tags:
FDA, Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes
Smith & Nephew sees more sector deals, not under investor pressure
Reuters
Friday, August 1, 2014 - 11:44am
tags:
Smith & Nephew, M&A, tax inversions, devices
Allergan Files Lawsuit in Federal Court against Valeant and Pershing Square for Violations of Federal Securities Laws
Marketwatch
Friday, August 1, 2014 - 11:43am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Cel-Sci's Enrollment Math Doesn't Add up
TheStreet.com
Friday, August 1, 2014 - 11:40am
tags:
head and neck cancer, Cel-Sci, Multikine
Do Layoffs in Biotech Send the Right Message?
24/7 Wall St
Friday, August 1, 2014 - 10:33am
tags:
biotech, Amgen, layoffs
The Best Blood Cancer Drug Launch Ever?
Forbes
Friday, August 1, 2014 - 10:27am
tags:
Pharmacyclics, Imbruvica, leukemia
As Sanofi Pushes to Grow Faster, a Key U.S. Exec is Leaving
WSJ Online
Friday, August 1, 2014 - 10:02am
tags:
Sanofi
Merck aims to boost HPV vaccination rates amid lagging numbers
Fierce Vaccines
Friday, August 1, 2014 - 9:40am
tags:
Merck, HPV, vaccines, Gardasil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.